TEVA

Teva Pharmaceutical Industries Limited

Sector: healthcareDrug Manufacturers - Specialty & GenericNYSEMarket Cap: $39.24B

Teva Pharmaceutical Industries Limited is a global generic and specialty pharmaceutical company with significant political exposure through $13.8M in annual doctor payments (2024) but no federal contracts, lobbying, or insider buys.

Govt Dependence

10/100

Regulatory Density

85/100

Lobbying Intensity

0/100

Political Signal

NEUTRAL

BusinessWhat TEVA does

Teva develops, manufactures, and markets generic and specialty medicines globally, with revenue lines including generic pharmaceuticals, specialty medicines (CNS, respiratory), and active pharmaceutical ingredients (APIs). The company operates in North America, Europe, and international markets.

12 months past · 3 months futureTEVA activity timeline

Congress

buy sell

Insider · Form 4

open-market buy

Hedge fund · 13F

opened + added − trimmed closed holds

Bills

past action (this ticker) upcoming markup (sector) ★ carveout (this ticker)

240 trading days · 0 congressional trades shown · 0 insider buys · 11 13F filings · 3 past bill actions · 16 upcoming markups

Lifetime Government AwardsTEVA federal contracts

TEVA doesn't hold direct federal contracts.

Verified via USASpending.gov: $0 reported in direct prime-contract awards. Companies in this position typically sell federal services indirectly through prime contractors and integrators (e.g., Lockheed Martin, Booz Allen, Microsoft Azure) or through commercial channels that don't appear in USASpending data.

Smart Money · 13F HoldingsHedge funds holding TEVA

$2.37B

Total TEVA held by tracked 13F funds

Funds with TEVA positions

+40

Funds opened this quarter

Viking Global Investors $196M opened 2025-06-30

Viking Global Investors $156M opened 2025-03-31

Renaissance Technologies $154M opened 2024-12-31

Renaissance Technologies $146M opened 2024-09-30

Viking Global Investors $143M opened 2024-12-31

Renaissance Technologies $142M opened 2024-06-30

Viking Global Investors $136M opened 2024-09-30

Citadel Advisors $115M opened 2025-12-31

32 more 13F positions tracked · quarterly delta charts available in member dashboard

Congressional TradesWho in Congress is trading TEVA

2020-11-13 (unknown) Purchase $15,001 - $50,000

2020-11-13 (unknown) purchase $15,001 - $50,000

2020-05-07 (unknown) Sale $1,001 - $15,000

2020-05-07 (unknown) sale $1,001 - $15,000

2019-06-19 (unknown) sale $1,001 - $15,000

2019-06-19 (unknown) Sale $1,001 - $15,000

2018-02-12 (unknown) purchase $15,001 - $50,000 49d late

2018-02-12 (unknown) Purchase $15,001 - $50,000 49d late

2017-05-30 (unknown) sale $1,001 - $15,000 48d late

2017-05-30 (unknown) Sale (Full) $1,001 - $15,000 48d late

2017-06-15 Patty Murray D-Washington · senate Sale (Full) $1,001 - $15,000

2017-06-15 Patty Murray D-Washington · senate sale $1,001 - $15,000

30+ trades on file · most recent 2020-12-02

Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock

No Form 4 activity recorded in the last 180 days.

Bills Affecting TEVALive legislation impacting this stock

S.827 · 119th

Supporting Rural Veterans Access to Healthcare Services Act

Markup latest action 2025-07-30 MINIMAL

HR.1860 · 119th

Women Veterans Cancer Care Coordination Act

Committee latest action 2025-09-16 MINIMAL

HR.2068 · 119th

Veterans Patient Advocacy Act

Committee latest action 2025-06-12 MINIMAL

HR.2020 · 119th

New Mexico Rural Veteran Health Care Access Act

Committee latest action 2025-04-01 MINIMAL

S.999 · 119th

Public Health Improvement Act

Committee latest action 2025-03-12 MINIMAL

HR.2045 · 119th

Medicare Dental, Vision, and Hearing Benefit Act of 2025

Committee latest action 2025-03-11 MINIMAL

HR.2062 · 119th

To amend the Internal Revenue Code of 1986 to treat membership in a health care sharing ministry as a medical expense, and for oth

Committee latest action 2025-03-11 MINIMAL

HR.2048 · 119th

Metastatic Breast Cancer Access to Care Act

Committee latest action 2025-03-11 MINIMAL

HR.2085 · 119th

Mental Health Research Accelerator Act of 2025

Committee latest action 2025-03-11 MINIMAL

SJRES.36 · 119th

A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted b

Committee latest action 2025-03-11 MINIMAL

Political ProfileWhere TEVA sits in Washington

[object Object]

STRUCTURAL: High regulatory density (85) due to healthcare sector and doctor payment exposure ($13.8M in 2024). EVIDENTIARY: No federal contracts, lobbying, insider buys (tier F, 0 buys), or congressional trades. Net: Regulatory overhead without direct political engagement.

Regulatory ExposureThreats & opportunities

Regulatory threats

Increased scrutiny of doctor payments under transparency laws

HHS/CMS

"get_political_influence.doctor_payments shows $13.8M in 2024 payments to doctors by Teva Pharmaceuticals USA, Inc."

Regulatory opportunities

Potential generic drug legislation easing market entry

FDA

"Recent bill_impacts include multiple healthcare bills with low impact_ratios (0.0001-0.0002), indicating minor regulatory sensitivity"

Member intelligence layer

Live signals + predictions for TEVA — for Founders

The free page above gives you the public record. Members see the real-time intelligence layer on top of it:

Live 7-layer signal scores when Congress trades TEVA
Bill Pass Index v2 odds for every bill on the watch list
Iron Triangle alerts (committee × donor × trade)
SEC Form 4 cluster detection (CEO + CFO + director buys)
Whale-Opportunity expected-value ranking
Custom watchlist alerts via email + Discord

Become a Founder · $24.50/mo Locked rate forever · cancel anytime

Frequently AskedAbout TEVA & political exposure

Does Teva Pharmaceutical Industries Limited (TEVA) hold federal contracts?

No direct prime contracts reported in USASpending.gov for Teva Pharmaceutical Industries Limited. Companies in the semiconductor and AI hardware sectors often sell to the federal government via prime contractors and cloud resellers (Microsoft Azure, AWS, Lockheed Martin systems integration) rather than as direct primes.

Has Congress traded TEVA stock?

52 congressional trades by 11 unique members of Congress, most recently on 2020-11-13. See the Congressional Trading panel for politician-by-politician breakdown.

What is TEVA political risk profile?

Government dependence: 10/100. Lobbying intensity: 0/100. Political signal: neutral. Donor party split: R 0% / D 0%.

How does GovGreed track TEVA political activity?

GovGreed integrates STOCK Act congressional trade disclosures, FEC contributions, OGE executive-branch disclosures, USASpending federal contracts, Senate LDA lobbying filings, and SEC Form 4 corporate insider trades into a single queryable graph. TEVA data is updated daily from these official federal sources.

BusinessWhat TEVA does

12 months past · 3 months futureTEVA activity timeline

Lifetime Government AwardsTEVA federal contracts

Smart Money · 13F HoldingsHedge funds holding TEVA

Congressional TradesWho in Congress is trading TEVA

Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock

Bills Affecting TEVALive legislation impacting this stock

Political ProfileWhere TEVA sits in Washington

Regulatory ExposureThreats & opportunities

Regulatory threats

Regulatory opportunities

Live signals + predictions for TEVA — for Founders

Frequently AskedAbout TEVA & political exposure

Peer companiesCompare against

More on GovGreedKeep digging